Brain Tumor News!
Note: The comments under each article title are the opinion of our president, Al Musella, DPM,
and do not reflect official policy of the Musella Foundation!
10/17/01
Thalidomide Sends Melanoma Patient Into Remission
(Reuters)
... blood cancer called myelodysplastic syndrome, and it is under study as a treatment for kidney,
brain and lung cancers, as well as Kaposi's sarcoma-...... Louis University School of Medicine in Missouri used the drug because of its recognized anti-
tumor properties and because of their patient's situation....... scientists believe the drug fights cancer by both cutting off the blood supply to
tumors and by boosting the immune system's response to the disease....
10/17/01
Low Melatonin Raises Breast Cancer Risk
(ABCNEWS.com)
...One theory is that decreased levels of the
brain hormone melatonin are responsible, since this chemical is known to regulate daily sleep-wake...... which can be seen if humans are exposed to light during the night, may promote
tumor growth....
10/17/01
Cell Repair Weakness a Brain Cancer Marker
(HealthSCOUT)
A weakened ability of certain cells to repair damage to their genetic material seems to be an important indicator of the risk of the
brain cancer called glioma, a study finds.
10/16/01
Research Highlights Comprehensive Cancer Care Conference 2001 October 19-21
(PR Newswire)
... dollars studying promising synthetic drugs to block the growth of blood vessels that feed
tumors, many natural agents have anti-angiogenic properties....... botanicals and other natural compounds. 3:30 - 5 p.m., Potomac 1-2 Nutritional Treatment for
Brain Cancer: Best Case Series (repeated Sunday, October 21, 11:30 a.m....... to improve the efficacy of conventional treatments and significantly prolong life for
brain tumor patients....
10/16/01
DNA Repair Defect May Lead to Brain Tumor
(Reuters)
Researchers have discovered a defect in the body's natural DNA repair mechanisms that may cause a deadly form of
brain tumor called malignant glioma.
10/10/01
Franzen Up for National Book Award
(AP)
... 52 years old and a resident of Amherst, Mass., has had several operations for a
brain tumor and has failing eyesight....
10/10/01
Peregrine gets fast-track for brain cancer drug
(Reuters Securities)
Drug developer Peregrine Pharmaceuticals Inc. on Wednesday said the U.S. Food and Drug Administration granted the company's experimental
brain cancer drug an expedited review process if it is submitted for approval.
10/10/01
Introgen to Present at UBS Warburg Annual Healthcare Conference
(PR Newswire)
... trials for INGN 201 in additional cancer indications including prostate, ovarian, bladder,
brain, and breast cancer.......Introgen's second product candidate, INGN 241 (Adenoviral-mda7) for the treatment of solid
tumors, is in Phase I clinical development....
